Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standex International Corporation (NYSE: SXI) SEC filings page provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Standex’s financial performance, governance practices, executive compensation, and shareholder matters.
Standex submits a variety of forms, including Form 8-K current reports and its DEF 14A definitive proxy statement. Recent Form 8-K filings have covered topics such as the announcement of quarterly earnings, the results of the Annual Meeting of Shareholders, and changes in executive roles. Through these reports, investors can review information on segment performance across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, as well as commentary on revenue, margins, and capital allocation.
The company’s definitive proxy statement describes board leadership structure, board committees, strategy and risk oversight, ESG strategy and risks, director compensation, director independence, and stock ownership. It also details the items presented to shareholders for voting, including director elections, advisory votes on executive compensation, and ratification of the independent auditors.
On this page, filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy documents, helping users quickly identify topics such as shareholder vote outcomes, executive compensation disclosures, and significant corporate events reported on Form 8-K. Investors can use these summaries alongside the full-text filings to better understand Standex’s regulatory reporting and governance framework.
Standex International (SXI) reported Q1 FY2026 results for the three months ended September 30, 2025. Net sales were $217.4 million, up from $170.5 million, led by Electronics at $110.6 million and Engraving at $35.8 million. Diluted EPS was $1.25 versus $1.53 a year ago as expenses increased.
Operating income was $29.6 million and included $6.0 million of restructuring costs and $0.4 million of acquisition costs. Interest expense rose to $8.9 million from $1.0 million, reducing income from continuing operations to $15.8 million. Cash from operations was $16.8 million. Cash and equivalents were $98.7 million, and long‑term debt was $544.6 million.
The company advanced integration of recent deals: McStarlite (cash consideration $57.0 million net of cash acquired) and the Amran/Narayan Group (final allocation: identifiable intangibles $136.0 million, goodwill $298.4 million). An interest rate swap effective August 30, 2025 fixes $225 million of borrowings at 3.48% through August 30, 2028. A quarterly dividend of $0.32 per share was declared.
Standex International Corporation (SXI) filed an 8-K to furnish its earnings press release for the first quarter ended September 30, 2025. The press release is provided as Exhibit 99 and is incorporated by reference. The filing uses Item 2.02 (Results of Operations and Financial Condition) and also includes the Exhibit 104 Cover Page Inline XBRL file.
The company notes that the communication contains forward-looking statements subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, with risk factors referenced in the accompanying release and the company’s Form 10-K for the fiscal year ended June 30, 2025.
Standex International (SXI) reported an insider transaction by its VP, Chief HR Officer. A Form 4 shows 111 shares of common stock were forfeited at $244.87 on 10/24/2025 to cover taxes tied to the vesting of previously issued restricted stock. Following the transaction, the officer directly owned 7,311 shares.
Standex International Corporation (SXI) reported a routine insider equity grant. A director acquired 639 shares of Common Stock on 10/21/2025 at a stated price of $0, reflecting a restricted stock award under the company’s 2018 Omnibus Incentive Plan.
The award vests three years after the date of grant. Following this transaction, the reporting person’s beneficial ownership stands at 14,229 shares, held directly.
Standex International (SXI): A company director reported a grant of 639 restricted shares of common stock on 10/21/2025 at $0 under the company’s 2018 Omnibus Incentive Plan. The award is scheduled to vest three years after the grant date.
Following this transaction, the director’s beneficial ownership stands at 12,905.4464 shares, held directly. This filing records an equity compensation award and does not indicate any open‑market purchase or sale.
Standex International (SXI) reported an insider equity award. Director Alan J. Glass acquired 639 shares of common stock on 10/21/2025 via a restricted stock grant under the Company’s 2018 Omnibus Incentive Plan. The award carries a $0 price, reflecting a grant rather than an open‑market purchase, and vests three years after the date of grant.
Following this transaction, the reporting person beneficially owned 14,424 shares, held directly.
Standex International (SXI) reported an insider equity award. A company director acquired 639 shares of Common Stock on 10/21/2025 at $0 via a restricted stock grant under the 2018 Incentive Plan.
The award vests three years after the date of grant. After this transaction, the director beneficially owns 4,698.089 shares, held directly.
Standex International (SXI) disclosed a Form 4 indicating a director received 639 shares of common stock on 10/21/2025 as a restricted stock grant under the company’s 2018 Omnibus Incentive Plan.
The award was recorded at $0 per share and vests three years after the grant date. Following this transaction, the reporting person beneficially owns 6,285 shares, held directly.
Standex International (SXI) reported an insider equity award. A director received a grant of 639 shares of common stock on 10/21/2025, coded as an acquisition under the company’s 2018 Omnibus Incentive Plan. The grant price was $0, and the restricted stock is scheduled to vest three years after the grant date.
Following this grant, the reporting person beneficially owns 6,639 shares, held directly. This filing reflects routine director compensation in equity rather than an open‑market purchase or sale.
Standex International (SXI) director reported an equity grant. On 10/21/2025, the reporting person acquired 639 shares of common stock as a grant of restricted stock under the Company’s 2018 Omnibus Incentive Plan, vesting three years after the grant date. The filing lists the transaction price as $0, consistent with a stock grant. Following the grant, the filer beneficially owned 3,575 shares directly and 13,751 shares indirectly as trustee of a trust.